Left Ventricular Sphericity Index is a reproducible bedside echocardiographic measure of geometric change between acute phase Takotsubo's syndrome and acute anterior myocardial infarction by Khanna, Shaun et al.
IJC Heart & Vasculature 29 (2020) 100547Contents lists available at ScienceDirect
IJC Heart & Vasculature
journa l homepage: www. journals .e lsevier .com/ i j c -hear t -and-vascula tureLeft Ventricular Sphericity Index is a reproducible bedside
echocardiographic measure of geometric change between acute phase
Takotsubo’s syndrome and acute anterior myocardial infarctionhttps://doi.org/10.1016/j.ijcha.2020.100547
2352-9067/ 2020 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding author at: Department of Cardiology, Blacktown Hospital, 18
Blacktown Road, Blacktown, NSW 2148, Australia.
E-mail addresses: shaunkhanna@hotmail.com (S. Khanna), timothy.tan9@gmail.
com (T.C. Tan).Shaun Khanna a,⇑, Aditya Bhat a, Henry H. Chen a, Jeremy W.A. Tan a, Gary C.H. Gan a, Timothy C. Tan a,b,c
aDepartment of Cardiology, Blacktown Hospital, Blacktown Road, Blacktown, NSW 2148, Australia
bUniversity of New South Wales, Faculty of Medicine, Sydney, NSW 2052, Australia
cWestern Sydney University, Faculty of Medicine, Blacktown 2148, NSW, Australiaa r t i c l e i n f o
Article history:
Received 19 April 2020
Received in revised form 13 May 2020
Accepted 25 May 2020




Myocardial infarctiona b s t r a c t
Background: Left ventricular sphericity index (LVSI) is a simple, quick and reproducible measure to eval-
uate LV geometric changes. The aim of our study was to evaluate the utility of LVSI as a rapid discrimi-
nation tool in two disease processes; Takotsubo’s Syndrome (TS) and Anterior Myocardial Infarction
(AMI), in the absence of significant left ventricular systolic dysfunction.
Methods: Consecutive patients with acute phase TS admitted to our institution (Jan 2013 - Dec 2018)
were evaluated (n=66). Patients with a comprehensive two-dimensional transthoracic echocardiogram
were included in primary analysis (n=50) and age-matched with a cohort of patients with acute anterior
AMI (n=50). Appraisal of demographic, clinical and echocardiographic parameters of patients was under-
taken. Biplane LVSI was calculated as an average of the short- and long-axis length in the 4- and 2-
chamber apical views.
Results: A total of 50 TS patients (64.3±13.7 years, 18% men) were matched with 50 AMI (62.10±12.84
years, 74% men) patients. There was no significant difference in baseline cardiovascular risk factors other
than diabetes mellitus (AMI 34% vs TS 17%, p = 0.034). There was also no difference in LV mass (p=0.10) or
LVEF (p=0.52) between the two groups. Interestingly, there was a significant difference in mean LVSI
between TS (0.60±0.06) vs AMI (0.52±0.07) (p<0.01) reflecting a more spherical shaped left ventricle in
the acute TS group.
Conclusions: LVSI is reflective of geometric changes in the left ventricle and may be helpful as a rapid and
reproducible diagnostic tool in differentiating between TS and AMI in the acute phase.
 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Takotsubo’s syndrome (TS) has historically been defined as a
transient myocardial disease process resulting in a classical apical
hypokinesis with a reversible regional dilatation of the left ventri-
cle [1]. The pathogenesis of this entity is attributed to a cate-
cholamine surge, usually secondary to a physical and/or
emotional stressor [1,2]. The presentation of acute TS can be simi-
lar to that of an acute anterior myocardial infarction (AMI) [2].
Despite well-established pathognomonic morphological features
defining TS, distinguishing between the two conditions may not
be straightforward [3]. Both these conditions have very differentpathophysiological processes, though distinguishing between the
two conditions in the acute phase can be challenging especially
in more subtle cases where left ventricular systolic dysfunction is
not significantly impaired. We hypothesise that different LV geo-
metric shape changes may be associated with the different patho-
physiological processes hence could potentially be used to help
differentiate between both conditions with similar clinical acute
presentations.
Transthoracic echocardiography (TTE) is a simple and readily
available bedside tool which can provide first line imaging and
valuable information in patients with acute TS or AMI. However,
traditional echocardiographic measures of such as LV ejection frac-
tion (LVEF) and indexed LV mass (LVMI), can frequently be insuffi-
cient to differentiate between the two different pathologies in the
acute phase [4]. LVSI is an underutilised measurement of LV geom-
etry, a marker of LV remodelling, that can be easily obtained from
standard echocardiographic images [5,6]. LVSI has been validated
Fig. 1. (A) (Left): Left Ventricular Sphericity index in Takotsubo’s Syndrome (4.6/7.6 cm = 0.61). (B) (Right): Left Ventricular Sphericity index in Anterior Myocardial Infarction
(4.2/8.5 cm = 0.49).
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dilated cardiomyopathy (IDCM) and correlated with outcomes in
ACS populations [6–10]. However, the utility and value of this
imaging parameter in differentiating between acute phase TS and
AMI has never been studied. Hence the aim of our study was to
characterise the geometric changes between acute TS and AMIs
using LVSI.2. Methods
2.1. Study population
Patients with a clinical diagnosis of acute phase TS infarction
between January 2013 to December 2018 that presented to our
institution were retrospectively examined. Patients who were
>18 years of age presenting with clinical syndrome that is con-
sistent with TS and who underwent coronary angiography and
a comprehensive TTE within 72 h of admission which demon-
strated normal LVEF were included. These patients were age-
matched in a 1 to 1 ratio with patients presenting with an acute
ST elevation myocardial infarct (STEMI) within the same period.
Patients with ventricular or supra-ventricular arrhythmias, con-
genital heart disease, significant valvular heart disease or pros-
thetic valves, missing baseline clinical data or had poor quality
echo images were excluded. The study protocol was approved
by the Human Research and Ethics Committee of New South
Wales (1910-06 QA).Table 1
Baseline characteristics.
Baseline characteristics TS (n = 50) AMI (n = 50) p value
Age (years) 64.30 ± 13.80 62.10 ± 12.80 0.41
Men 9 (18%) 37 (74%) <0.01
Body mass index (kg/m2) 26.9 ± 8.3 29.1 ± 6.4 0.19
Peak Troponin Level 5145 ± 5925 27519 ± 33619 <0.01
Hyperlipidaemia 11 (22%) 18 (36%) 0.186
Hypertension 25 (50%) 23 (46%) 0.689
Diabetes Mellitus 7 (14%) 17 (34%) 0.034
Obesity 11 (22%) 15 (30%) 0.342.2. Transthoracic echocardiography
Standard transthoracic echocardiography was performed using
commercially available ultrasound equipment (EPIQ, Philips Med-
ical Systems, Andover, MA; GE E9, GE Healthcare, Milwaukee,
WI; GE 95, GE Healthcare, Milwaukee, WI) according to guideline
recommendations by the American Society of Echocardiography.
All echocardiographic images were saved in digital format and
analysis was performed offline by two investigators who were
blinded to the clinical data of the patient.
Left ventricular sphericity index (LVSI) was measured offline
by two independent researchers, blinded to the patient history
and condition. LVSI was calculated as LV basal radial length/lon-
gitudinal length, measured in both the apical 4- and 2-chamber
views during end-diastole (ED) and end-systole (ES) (see Fig. 1).
An average of four measurements of LVSI from 3 cardiac cycles
(i.e. ES/ED in apical 4-chamber and ES / ED in apical
2-chamber) was reported.2.3. Intra- and inter-observer variability
Intra- and inter-observer variability was assessed by repeating
LVSI in 20 randomly selected patients from the cohort >4 weeks
apart by the same investigator and by a second independent inves-
tigator. There was good inter- and intra-observer agreement for
the LVSI measurements, with an interclass correlation of 0.96 with
a 95% Confidence Interval of 0.90–0.99 and a coefficient of varia-
tion of 3.39 with a 95% Confidence Interval of 1.65–5.14.2.4. Statistical analysis
All statistical analyses were performed using commercially
available software (SPSS version 22; SPSS Inc, Chicago, IL, USA).
Variable distribution was reported as mean and standard deviation
for normally distributed variables, median and interquartile range
for non-normally distributed variables or as percentage for cate-
gorical variables. Comparison between mean values between TS
and AMI groups was performed with Student T test for unpaired
data or ANOVA with analysis of variance and Bonferroni correction.
Categorical variables were compared with Chi - square test (with
Yates correction) or with Fisher test. All tests were 2-tailed. A p
value of <0.05 was considered as statistically significant.3. Results
3.1. Baseline characteristics
The final cohort consisted of 100 patients, which included 50
patients with diagnosed acute TS (64.3 ± 13.7 years, 18% men)
and 50 patients with anterior STEMI (62.10 ± 12.84 years, 74%
men). Patients in the AMI population had higher rates of diabetes
mellitus (p = 0.03) but no other significant differences in the base-
line characteristics between groups. See Table 1.
Table 2
Echocardiographic parameters.
Echocardiographic parameters TS (n = 50) AMI (n = 50) p
value
LVEDd (cm) 4.49 ± 0.71 4.56 ± 0.57 0.55
LVESd (cm) 3.03 ± 0.69 3.75 ± 4.62 0.29
IVS thickness (cm) 0.98 ± 0.21 1.10 ± 0.24 0.01
PW thickness (cm) 0.96 ± 0.17 1.03 ± 0.19 0.06
LV ejection fraction (%) 54.30 ± 12.01 53.27 ± 13.60 0.69
LVEDv (mL) 94.64 ± 33.57 100.59 ± 30.69 0.36
LVESv (mL) 39.39 ± 15.90 42.92 ± 20.18 0.34
LV mass (g/m2) 93.15 ± 28.57 93.09 ± 29.18 0.10
Mitral E velocity (cm/s) 0.73 ± 0.26 0.77 ± 0.23 0.51
Mitral A velocity (cm/s) 0.75 ± 0.28 0.82 ± 0.26 0.20
Mitral E/A ratio 1.06 ± 0.50 0.98 ± 0.40 0.45
Deceleration time of E velocity
(ms)
0.20 ± 0.08 0.19 ± 0.07 0.50
LVSI (ratio) 0.60 ± 0.06 0.52 ± 0.07 <0.01
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Baseline TTE data was compared between the two groups. No
significant differences were seen between the two groups in terms
of LV size and function (TS LVEF 54 ± 12% vs AMI LVEF 53 ± 14%,
p = 0.69). There were no significant differences in diastolic param-
eters (mitral E’, A’, E/A ratio or deceleration time) between the two
groups. However, there was a significant difference in calculated
LVSI between the two groups (TS 0.6 ± 0.6 vs AMI 0.5 ± 0.7,
p < 0.01) which suggested that patients with acute TS had more
spherical shaped left ventricles in the compared to acute anterior
MI patients. See Table 2.4. Discussion
This study attempted to characterise left ventricular geometric
changes using a quantitative measure of LV shape i.e. LVSI between
acute phase TS and AMI, two fundamentally different cardiac
pathologies but with similar clinical presentations. Our results
indicate that in acute phase TS process, the LV adopts a more
spherical morphology compared to patients with anterior STEMI
[11]. Due to large similarities in clinical history, examination, elec-
trocardiography and traditional echocardiographic findings of
regional wall motion abnormalities differentiation between the
two conditions can be difficult particularly if left ventricular sys-
tolic function is within normal limits [12,13]. The present gold-
standard investigation which differentiates between these two
pathologies is coronary angiography. More recently, echo mea-
sures of left ventricular function such as global longitudinal strain,
have been proposed to be potentially useful for assisting discrimi-
nation between TS and AMI as it is able to provide information seg-
mental wall motion abnormalities [14,15]. However, measurement
of longitudinal strain may not be technically possible in situations
where there is poor visualisation of the endocardium, and in such
situations LVSI may be larger benefit as an additional non-invasive
discriminator.
We hypothesised that different patho-physiological processes
result in differential LV geometric changes which may then be used
to help differentiate between two different conditions with similar
clinical presentations. With AMI, early LV remodelling occurs in
the left anterior descending coronary artery territory from micro-
and macro-vascular ischemia and resultant necrosis. This process
typically affects the anterior and apical walls, however does not
affect inferior and inferolateral segments as these are typically
supplied by the circumflex and right coronary arteries. TS, how-
ever, is a result of catecholamine-induced ventricular dysfunction,
with a classical apical hypokinesis and basal hyperkinesis appear-ance. However, the classical pathognomonic morphological
appearance which is typically described in TS (with variable sensi-
tivity) is only a qualitative diagnostic assessment for TS [16]. Given
the subjective nature of this assessment, there can be difficulty in
the diagnosis particularly in subtle cases. Given the relatively
higher burden of myocardial involvement not ascribed to a coro-
nary artery territory, there is complete circumferential involve-
ment of the mid-segment including the inferior and inferolateral
regions of the left ventricle [17,18]. Therefore, this tool may be of
benefit in assisting discrimination of these two pathologies, espe-
cially in patients who have contraindications to conventional coro-
nary angiography or are too unstable to undergo procedural
therapy.
The major limitations of our study include the small but well-
defined sample size and retrospective design of the study. The
other limitations included the inability to exclude such morpho-
logic patterns prior to the onset of the acute pathologies and the
effect of pre-existing cardiovascular comorbidities (i.e. hyperten-
sion) in influencing LV morphological changes.
5. Conclusions
The LVSI parameter provides a simple but more objective quan-
tification of LV geometric changes, and hence could potentially be
used as an additional quantitative tool in discriminating these two
pathologies in addition to standard diagnostic criteria. Further
studies are still required to better characterise the application of
this measure in a clinical setting.
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